AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ELEVRA LITHIUM LTD

9.080

+0.3604.13%

Volume:1.13M

Turnover:10.12M

Market Cap:1.76B

PE:-5.41

High:9.250

Open:8.600

Low:8.520

Close:8.720

52wk High:14.060

52wk Low:2.700

Shares:194.02M

Float Shares:166.89M

Volume Ratio:0.88

T/O Rate:0.68%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.677

EPS(LYR):-5.714

ROE:-26.34%

ROA:-8.87%

PB:2.23

PE(LYR):-1.59

Loading ...

Overview Company News Filings

BRIEF-Elevra Lithium Posts Qtrly Revenue $81 Million For North American Lithium

Stock Track | Elevra Lithium Soars 5.17% Intraday on Strong Quarterly Results and Operational Improvements

Elevra Lithium Ltd - Elevra Has Only Limited Exposure to Liquid Fuel Prices and Reduced Fuel Availability for North American Lithium

THOMSON REUTERS

Elevra Lithium Ltd - Qtrly North American Lithium Spodumene Concentrate Production up 7% Qoq to 47,332 Dmt at 5.0% Grade

THOMSON REUTERS

Elevra Lithium Ltd: Reaffirms FY26 Production Guidance of 180,000–190,000 Dmt, Sales Guidance of 170,000– 190,000 Dmt

THOMSON REUTERS

GUIDANCE: (ELV) Elevance Health Expects 2026 Adjusted EPS of At Least $26.75, vs. FactSet Est of $25.77

MT Newswires Live

Assessing Elevance Health (ELV) Valuation As Shares Show Short Term Momentum But Longer Term Weakness

Simply Wall St.

Elevra Lithium to release March-quarter activities report, host investor webcast

A Look At Elevance Health (ELV) Valuation After Earnings Beat EPS But Missed Revenue And Membership Declines

Simply Wall St.

Elevra Lithium Says BNY Mellon Cuts Stake

MT Newswires Live

President & COO of Canada Of Elevra Lithium Sold 33% Of Their Shares

Simply Wall St.

Is It Time To Reassess Elevance Health (ELV) After A 26% One-Year Share Price Fall

Simply Wall St.

A Look At Elevance Health (ELV) Valuation After Strong Q4 Results Dividend Hike And Leadership Changes

Simply Wall St.

Is It Time To Reassess Elevance Health (ELV) After A 33% One‑Year Share Price Slide

Simply Wall St.

Morella Completes Reverse Circulation Drilling at Western Australia Rubidium-Lithium Project; Shares Jump 7%

MT Newswires Live

Evaluating Elevance Health (ELV) After Q4 Results And 2026 Earnings Target Update

Simply Wall St.

Elevra Lithium Says BNY Mellon Reduces Stake

MT Newswires Live

Elevra Lithium director Jorge Mariano Beristain files initial beneficial ownership statement

Elevra Lithium director Allan Charles Buckler files initial beneficial ownership statement

Elevra Lithium files Form 3 for President Canada and Group COO Sylvain Collard

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/ELV.AU/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ELV.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ELV.AU\",,,,,undefined,":{"symbol":"ELV.AU","market":"AU","secType":"STK","nameCN":"ELEVRA LITHIUM LTD","latestPrice":9.08,"timestamp":1787292720000,"preClose":8.72,"halted":0,"volume":1129215,"delay":0,"changeRate":0.041284403669724704,"nameEN":"ELEVRA LITHIUM LTD","floatShares":166890429,"shares":194016000,"eps":-1.6774689549323287,"marketStatus":"Not Yet Opened","change":0.36,"latestTime":"08-21 16:12:00 AEST","open":8.6,"high":9.25,"low":8.52,"amount":10121054,"amplitude":0.083716,"askPrice":9.13,"askSize":1000,"bidPrice":8.9,"bidSize":7303,"shortable":3,"etf":0,"ttmEps":-1.6774689549323287,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":8.72,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0.8791717086587822,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ELV.AU","preClose":8.72,"auctionPrice":9.07,"auctionVolume":135940,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292600773}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ELV.AU\",,,,,undefined,":{"symbol":"ELV.AU","floatShares":166890429,"roa":"-8.87%","roe":"-26.34%","lyrEps":-5.71382,"volumeRatio":0.8791717086587822,"shares":194016000,"dividePrice":0,"high":9.25,"amplitude":0.083716,"preClose":8.72,"low":8.52,"week52Low":2.7,"pbRate":"2.23","psRate":"8.14","week52High":14.06,"institutionHeld":0,"latestPrice":9.08,"committee":0.759123,"eps":-1.6774689549323287,"divideRate":0,"volume":1129215,"delay":0,"ttmEps":-1.6774689549323287,"open":8.6,"prevYearClose":8.04,"prevWeekClose":9.2,"prevMonthClose":7.46,"prevQuarterClose":9.6,"fiveDayClose":9.2,"twentyDayClose":7.75,"sixtyDayClose":12.35,"earningDate":1787846400000,"dividendPayoutRate":0,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELV.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"ELV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787875200000,"name":null,"time":"","dateTimestamp":1787839200000,"actualEps":null},{"date":"2026-07-28","symbol":"ELV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1785196800000,"name":null,"time":"","dateTimestamp":1785160800000,"actualEps":null},{"date":"2026-04-23","symbol":"ELV.AU","type":"earning","reportTimeType":"pre","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776902400000,"name":null,"time":"Pre-MKt","dateTimestamp":1776866400000,"actualEps":null},{"date":"2026-02-24","symbol":"ELV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771887600000,"name":null,"time":"","dateTimestamp":1771851600000,"actualEps":null},{"date":"2026-01-28","symbol":"ELV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1769554800000,"name":null,"time":"","dateTimestamp":1769518800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELV.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELV.AU\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2629708370","title":"BRIEF-Elevra Lithium Posts Qtrly Revenue $81 Million For North American Lithium","url":"https://stock-news.laohu8.com/highlight/detail?id=2629708370","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629708370?lang=en_us&edition=fundamental","pubTime":"2026-04-23 09:33","pubTimestamp":1776908035,"startTime":"0","endTime":"0","summary":"BRIEF-Elevra Lithium Posts Qtrly Revenue $81 Million For North American LithiumApril 23  - Elevra Lithium Ltd ELV.AX:QTRLY REVENUE RISES 22% TO $81 MILLION FOR NORTH AMERICAN LITHIUMREAFFIRMS FY26 PRODUCTION GUIDANCE OF 180,000–190,000 DMT, SALES GUIDANCE OF 170,000–  190,000 DMTQTRLY NORTH AMERICAN LITHIUM SPODUMENE CONCENTRATE PRODUCTION UP 7% QOQ TO 47,332 DMT AT 5.0% GRADEELEVRA HAS ONLY LIMITED EXPOSURE TO LIQUID FUEL PRICES AND REDUCED FUEL AVAILABILITY FOR NORTH AMERICAN LITHIUMFurther company coverage: ELV.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nFWN4150X6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","ELV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135209972","title":"Stock Track | Elevra Lithium Soars 5.17% Intraday on Strong Quarterly Results and Operational Improvements","url":"https://stock-news.laohu8.com/highlight/detail?id=1135209972","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135209972?lang=en_us&edition=fundamental","pubTime":"2026-04-23 08:33","pubTimestamp":1776904387,"startTime":"0","endTime":"0","summary":"ELEVRA LITHIUM LTD's stock experienced a significant surge of 5.17% during intraday trading on Thursday. The sharp upward movement reflects strong investor sentiment following the release of the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ELV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629951076","title":"Elevra Lithium Ltd - Elevra Has Only Limited Exposure to Liquid Fuel Prices and Reduced Fuel Availability for North American Lithium","url":"https://stock-news.laohu8.com/highlight/detail?id=2629951076","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629951076?lang=en_us&edition=fundamental","pubTime":"2026-04-23 06:12","pubTimestamp":1776895921,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nFWN4150X6:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","ELV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629076955","title":"Elevra Lithium Ltd - Qtrly North American Lithium Spodumene Concentrate Production up 7% Qoq to 47,332 Dmt at 5.0% Grade","url":"https://stock-news.laohu8.com/highlight/detail?id=2629076955","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629076955?lang=en_us&edition=fundamental","pubTime":"2026-04-23 06:12","pubTimestamp":1776895921,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nFWN4150X6:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELV.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629076953","title":"Elevra Lithium Ltd: Reaffirms FY26 Production Guidance of 180,000–190,000 Dmt, Sales Guidance of 170,000–  190,000 Dmt","url":"https://stock-news.laohu8.com/highlight/detail?id=2629076953","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629076953?lang=en_us&edition=fundamental","pubTime":"2026-04-23 06:12","pubTimestamp":1776895921,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nFWN4150X6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","ELV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629201476","title":"GUIDANCE: (ELV) Elevance Health Expects 2026 Adjusted EPS of At Least $26.75, vs. FactSet Est of $25.77","url":"https://stock-news.laohu8.com/highlight/detail?id=2629201476","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629201476?lang=en_us&edition=fundamental","pubTime":"2026-04-22 18:04","pubTimestamp":1776852293,"startTime":"0","endTime":"0","summary":"GUIDANCE: (ELV) Elevance Health Expects 2026 Adjusted EPS of At Least $26.75, vs. FactSet Est of $25.77","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ELV","ELV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629004407","title":"Assessing Elevance Health (ELV) Valuation As Shares Show Short Term Momentum But Longer Term Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2629004407","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629004407?lang=en_us&edition=fundamental","pubTime":"2026-04-21 13:05","pubTimestamp":1776747911,"startTime":"0","endTime":"0","summary":"Elevance Health stock snapshot and recent moves\nElevance Health (ELV) has been trading around US$319.36, with a return of about 9.6% over the past month but a return of roughly 13% decline over the past 3 months.\nSee our latest analysis for Elevance Health.\nShort term share price momentum has picked up, with a 1 month share price return of 9.6%. However, this follows a 3 month share price return decline of 13% and a 1 year total shareholder return decline of 19.8%, which suggests sentiment...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/assessing-elevance-health-elv-valuation-as-shares-show-short","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/assessing-elevance-health-elv-valuation-as-shares-show-short","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2237957811.SGD","LU0345770308.USD","LU0070302665.USD","LU0208291251.USD","LU0058720904.USD","SGXZ23171101.USD","LU1023059063.AUD","LU0211331839.USD","LU0251131958.USD","LU2362541273.HKD","LU0640476718.USD","LU0878866978.SGD","LU0320765489.SGD","LU2430703178.SGD","LU0068578508.USD","LU1720051017.SGD","LU1057294990.SGD","LU2362540622.SGD","LU0006306889.USD","LU0477156953.USD","LU1548497426.USD","LU2505996509.AUD","LU2430703251.USD","LU2362541513.USD","ELV","LU1280957306.USD","ELV.AU","LU0114720955.EUR","LU0048573561.USD","LU0170899867.USD","LU0225283273.USD","LU0433182093.SGD","LU2430703095.HKD","LU1815333072.USD","LU2237957902.USD","LU1670628061.USD","LU0130102774.USD","LU1670627923.USD","LU2505996681.GBP","LU1506573853.SGD","LU0957791311.USD","LU0980610538.SGD","LU1983299246.USD","LU0648001328.SGD","LU0061474960.USD","BK7095","LU0234570918.USD","LU0266013472.USD","LU0345770993.USD","LU0251142724.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627230875","title":"Elevra Lithium to release March-quarter activities report, host investor webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2627230875","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627230875?lang=en_us&edition=fundamental","pubTime":"2026-04-16 04:16","pubTimestamp":1776284205,"startTime":"0","endTime":"0","summary":"Elevra Lithium scheduled release of March 2026 Quarterly Activities Report for April 23, 2026.Investor webcast set for April 23, 2026 at 9:30 a.m. AEST, or April 22, 2026 at 7:30 p.m. ET.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL2qDnmt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","ELV.AU","BK4585","NDAQ","IE00BN0W2W23.USD","SG9999014005.SGD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","LU0314104364.USD","SG9999014039.USD","SG9999014013.SGD","BK7095","BK4112","LU2210149790.SGD","BK4588","IE00B3QW5Z07.USD","SG9999014021.USD","IE00BN0W2V16.EUR","CXO.AU","BK7504","IE00B64PRP62.GBP","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627671344","title":"A Look At Elevance Health (ELV) Valuation After Earnings Beat EPS But Missed Revenue And Membership Declines","url":"https://stock-news.laohu8.com/highlight/detail?id=2627671344","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627671344?lang=en_us&edition=fundamental","pubTime":"2026-04-14 08:43","pubTimestamp":1776127427,"startTime":"0","endTime":"0","summary":"Elevance Health (ELV) is in focus after reporting earnings with adjusted EPS above expectations but revenue below forecasts, while also disclosing declines in Medicaid and Medicare Advantage membership.\nSee our latest analysis for Elevance Health.\nThe stock has reacted to these mixed signals with a 1-day share price return of 1.46% and a 7-day share price return of 4.45%. However, the 1-year total shareholder return of 26.83% and 3-year total shareholder return of 31.50% point to weaker...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/a-look-at-elevance-health-elv-valuation-after-earnings-beat","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/a-look-at-elevance-health-elv-valuation-after-earnings-beat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ELV.AU","ELV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627819474","title":"Elevra Lithium Says BNY Mellon Cuts Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2627819474","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627819474?lang=en_us&edition=fundamental","pubTime":"2026-04-13 13:44","pubTimestamp":1776059071,"startTime":"0","endTime":"0","summary":"Elevra Lithium  said The Bank of New York Mellon Corporation and its group entities have reduced their stake in the company on April 9 to 22.32% or 37.8 million shares from 23.33% or 39.5 million shares, according to a Monday Australian bourse filing.The company's shares fell 2% in recent Monday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SETM","ELV.AU","LIT","BK4588","BK4585","BK7095","BNY","BK4168","ELVR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626151477","title":"President & COO of Canada Of Elevra Lithium Sold 33% Of Their Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2626151477","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626151477?lang=en_us&edition=fundamental","pubTime":"2026-04-10 08:26","pubTimestamp":1775780818,"startTime":"0","endTime":"0","summary":"We'd be surprised if Elevra Lithium Limited ( ASX:ELV ) shareholders haven't noticed that the President & COO of...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/president-coo-of-canada-of-elevra-lithium-sold-33-of-their-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/president-coo-of-canada-of-elevra-lithium-sold-33-of-their-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4198","GB00BDT5M118.USD","LU1992135472.HKD","LU2211815571.USD","ELV.AU","BK7095","BK4588","ELVR","LIT","BK4585","BK4168","SETM","COO","LU2272731782.SGD","LU1992135399.USD","LU2272731600.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626922175","title":"Is It Time To Reassess Elevance Health (ELV) After A 26% One-Year Share Price Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2626922175","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626922175?lang=en_us&edition=fundamental","pubTime":"2026-04-09 04:22","pubTimestamp":1775679777,"startTime":"0","endTime":"0","summary":"Wondering if Elevance Health at around US$311 a share still offers value, or if the best entry point has passed? This article walks through the key numbers that matter for you.\nThe stock has returned 6.5% over the last week and 7.7% over the last month, yet it remains 12.0% lower year to date and 26.1% lower over the last year, which sets an interesting backdrop for thinking about risk and value.\nRecent attention on Elevance Health has focused on its position in the US healthcare sector and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/is-it-time-to-reassess-elevance-health-elv-after-a-26-one-ye","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/is-it-time-to-reassess-elevance-health-elv-after-a-26-one-ye","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0477156953.USD","LU2505996509.AUD","ELV","LU0170899867.USD","LU1548497426.USD","DCF","LU0314106906.USD","LU0648001328.SGD","LU1489326972.SGD","LU1720051017.SGD","ELV.AU","LU0320765489.SGD","LU2362541273.HKD","BK4154","LU1506573853.SGD","LU1201861249.SGD","LU1280957306.USD","LU0251142724.SGD","LU0187121727.USD","LU0130517989.USD","FCF","LU0234570918.USD","LU0006306889.USD","LU0122379950.USD","LU1983299246.USD","LU1720051108.HKD","SGXZ23171101.USD","LU1670628061.USD","LU0980610538.SGD","BK4585","LU0211331839.USD","LU2592432038.USD","LU2430703178.SGD","LU2244417387.USD","LU0130102774.USD","LU0878866978.SGD","LU0433182093.SGD","LU0557290698.USD","LU0640476718.USD","LU1023059063.AUD","LU0061474960.USD","LU2505996681.GBP","LU0106261372.USD","LU2362540622.SGD","LU1057294990.SGD","LU2362541513.USD","LU0742534661.SGD","LU0225283273.USD","LU0882574055.USD","LU2357305700.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625648776","title":"A Look At Elevance Health (ELV) Valuation After Strong Q4 Results Dividend Hike And Leadership Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2625648776","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625648776?lang=en_us&edition=fundamental","pubTime":"2026-04-05 10:23","pubTimestamp":1775355789,"startTime":"0","endTime":"0","summary":"Elevance Health (ELV) is back in focus after strong fourth quarter earnings, a higher dividend, updated full year guidance, and a flurry of senior appointments across its Health Benefits and Carelon units.\nSee our latest analysis for Elevance Health.\nThe recent leadership reshuffle, strong fourth quarter results, higher dividend, and updated guidance have helped the share price rebound, with a 7 day share price return of 5.01% and a 30 day share price return of 4.98%. However, the 1 year...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/a-look-at-elevance-health-elv-valuation-after-strong-q4-resu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/a-look-at-elevance-health-elv-valuation-after-strong-q4-resu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2430703178.SGD","ELV","LU0061474960.USD","LU2362541513.USD","LU0130102774.USD","BK4585","LU0320765489.SGD","LU0266013472.USD","LU1506573853.SGD","LU2505996509.AUD","LU1201861249.SGD","LU0477156953.USD","LU0187121727.USD","LU0070302665.USD","LU0048573561.USD","ELV.AU","LU0878866978.SGD","LU0648001328.SGD","LU1023059063.AUD","LU1720051017.SGD","LU2108987350.USD","LU2430703251.USD","LU0068578508.USD","LU0058720904.USD","LU0314106906.USD","LU2592432038.USD","LU1670628061.USD","BK4588","LU0225283273.USD","LU0640476718.USD","LU1548497426.USD","LU2362541273.HKD","LU0211331839.USD","LU0957791311.USD","LU0006306889.USD","BK4154","LU0251131958.USD","SG9999003800.SGD","LU1720051108.HKD","LU0234570918.USD","LU2237957811.SGD","LU1057294990.SGD","LU0106261372.USD","LU0170899867.USD","LU0289739699.SGD","LU0980610538.SGD","LU0433182093.SGD","LU0130517989.USD","LU2505996681.GBP","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623309535","title":"Is It Time To Reassess Elevance Health (ELV) After A 33% One‑Year Share Price Slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2623309535","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623309535?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:16","pubTimestamp":1774970189,"startTime":"0","endTime":"0","summary":"If you are wondering whether Elevance Health's current share price reflects its true worth, this article will walk you through what the numbers actually say.\nRecently, the stock has retreated, with returns of a 1.5% decline over 7 days, an 11.0% decline over 30 days, a 19.6% decline year to date, and a 33.1% decline over the past year from a last close of US$284.79.\nThese moves have arrived alongside ongoing sector attention on large managed care names and investor focus on how insurers are...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/is-it-time-to-reassess-elevance-health-elv-after-a-33-oneyea","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/is-it-time-to-reassess-elevance-health-elv-after-a-33-oneyea","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0433182093.SGD","LU2505996681.GBP","LU2237957902.USD","LU2505996509.AUD","LU0130102774.USD","LU0070302665.USD","LU0882574055.USD","SG9999004303.SGD","LU0320765489.SGD","LU1670628061.USD","LU0557290698.USD","LU0122379950.USD","LU1057294990.SGD","LU0345770993.USD","LU0211331839.USD","LU0006306889.USD","LU0742534661.SGD","SG9999011175.SGD","LU0648001328.SGD","LU0187121727.USD","LU2244417387.USD","BK7095","SG9999001077.SGD","LU2362541273.HKD","LU0061474960.USD","LU0208291251.USD","BK4585","ELV","LU0048573561.USD","LU1548497426.USD","LU0225283273.USD","LU1720051108.HKD","LU0234570918.USD","DCF","LU1280957306.USD","LU1489326972.SGD","LU0251131958.USD","LU2237957811.SGD","LU2108987350.USD","LU0114720955.EUR","LU2430703251.USD","LU2362541513.USD","SG9999003800.SGD","LU1983299246.USD","LU1720051017.SGD","LU2592432038.USD","LU0878866978.SGD","ELV.AU","BK4588","LU0640476718.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623320904","title":"Morella Completes Reverse Circulation Drilling at Western Australia Rubidium-Lithium Project; Shares Jump 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623320904","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623320904?lang=en_us&edition=fundamental","pubTime":"2026-03-31 07:56","pubTimestamp":1774914996,"startTime":"0","endTime":"0","summary":"Morella  completed a reverse circulation drilling program at the Mt Edon rubidium-lithium project in Western Australia, with 20 holes drilled for around 1,700 meters, according to a Tuesday Australian bourse filing.The drilling was part of Morella's joint venture strategy with Elevra Lithium .Geological logging confirmed widespread pegmatite development across the Sophie prospect, with intercepts including 84 meters of pegmatite from 18 meters as well as 53 meters of pegmatite from three meters. 11 drill holes returned pegmatite intercepts exceeding 30 meters.Shares of Morella jumped 7% in early trading on Tuesday, while those of Elevra fell 2%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK7095","1MC.AU","BK4168","XAO.AU","LIT","BK7504","ELV.AU","WRN","XKO.AU","BK4585","XJO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622877601","title":"Evaluating Elevance Health (ELV) After Q4 Results And 2026 Earnings Target Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2622877601","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622877601?lang=en_us&edition=fundamental","pubTime":"2026-03-28 03:11","pubTimestamp":1774638676,"startTime":"0","endTime":"0","summary":"Q4 Earnings Put Elevance Health (ELV) in Focus\nElevance Health (ELV) moved back into the spotlight after reporting fourth quarter and full-year 2025 results, highlighting Medicaid and Medicare Advantage pressures alongside Health Benefits revenue growth and a 2026 adjusted EPS target of at least $25.50.\nSee our latest analysis for Elevance Health.\nAt a share price of US$294.25, Elevance Health has seen a 10.05% 1 month share price decline and a 16.94% year to date share price decline, while...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/evaluating-elevance-health-elv-after-q4-results-and-2026-ear","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/evaluating-elevance-health-elv-after-q4-results-and-2026-ear","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ELV","ELV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621722100","title":"Elevra Lithium Says BNY Mellon Reduces Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2621722100","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621722100?lang=en_us&edition=fundamental","pubTime":"2026-03-23 14:20","pubTimestamp":1774246833,"startTime":"0","endTime":"0","summary":"Elevra Lithium(ASX:ELV) said The Bank of New York Mellon and its units have reduced their stake in the company on March 19 to 23.33% or 39.5 million shares from 24.38% or 41.3 million shares, according to a Monday Australian bourse filing.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LIT","BK7095","ELV.AU","BK4168","BK4588","BK4585","ELVR","BNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621875192","title":"Elevra Lithium director Jorge Mariano Beristain files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2621875192","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621875192?lang=en_us&edition=fundamental","pubTime":"2026-03-21 04:18","pubTimestamp":1774037933,"startTime":"0","endTime":"0","summary":"Elevra Lithium director Jorge Mariano Beristain reported directly holding 14,903 American Depositary Shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elevra Lithium Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nNDL5thywx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","ELV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621638751","title":"Elevra Lithium director Allan Charles Buckler files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2621638751","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621638751?lang=en_us&edition=fundamental","pubTime":"2026-03-21 04:10","pubTimestamp":1774037444,"startTime":"0","endTime":"0","summary":"Elevra Lithium reported that director Allan Buckler beneficially owned 275,510 ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elevra Lithium Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nNDLb67B9y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","ELV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620719182","title":"Elevra Lithium files Form 3 for President Canada and Group COO Sylvain Collard","url":"https://stock-news.laohu8.com/highlight/detail?id=2620719182","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620719182?lang=en_us&edition=fundamental","pubTime":"2026-03-20 05:05","pubTimestamp":1773954315,"startTime":"0","endTime":"0","summary":"Sylvain Collard, President Canada and Group COO of Elevra Lithium, filed a Form 3 reporting 40,925 ordinary shares held directly.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elevra Lithium Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 19, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL2GSh3Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELV.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":6,"totalSize":128,"code":"91000000","status":"200"}]}}